PLPL news update on new Microsoft exec as new VP

New Post Public Reply Private Reply Replies (0) Message Board
TradeForProfits
PLPL news update on new Microsoft exec as new VP marketing: Future of Plandai Biotechnology's Products in Good Hands With Former Microsoft Executive Heading Up Global Marketing
NEW YORK, NY--(Marketwired - Feb 25, 2014) - Today Plandaí Biotechnology (OTCQB: PLPL) named former Microsoft executive Jamen Shively as the company's Vice President of Global Marketing. Shively has an extensive and impressive resume in the world of business, and the company is confident he can deliver Plandaí's products on the world stage. According to Plandaí, Shively will be responsible for building brand awareness and marketing strategy for all of the company's operations. Needless to say, they found just the right man for the future of their products.
Since leaving Microsoft, Shively has become a marijuana entrepreneur who has the ability to command the media's attention. So, having Shively build brand awareness for the company's products, including, the Diego Pellicer® medical cannabis line as well as the Phytofare™ botanical extracts such as the Green Tea Catechin Complex and the Limonoid Glycoside Complex is a brilliant move by Plandaí executives.
Shively co-founded Diego Pellicer Inc. in 2012, and then built the brand into the most recognized brand of cannabis in the world in less than one year. Prior to founding Diego Pellicer, Jamen was a Corporate Strategy Manager for Microsoft from 2003 to 2009, where he focused on the creation and development of new categories of software products and online services.
Plandaí's CEO stated it is their goal to become the leading name in highly bioavailable botanical extracts for both nutraceutical and pharmaceutical applications. Jamen Shively is someone who can make that a reality, and he sounds more than ready to get started. "We have a unique opportunity with Plandaí's technology to fundamentally change how we address wellness, health and prevention through natural, botanical solutions."
Shively said he's also excited about the application of Plandaí's technologies to cannabis. He stated, "I believe they'll revolutionize the application of cannabis to preventive and therapeutic health, under the Diego Pellicer brand. This is the opportunity of a lifetime for me and for my colleagues at Plandai to change the world by improving the health and wellness of mankind through 100% natural plant extracts."
Shively's deep interest in the marijuana arena will serve Plandaí well, and his expertise will likely make the company a leading name in highly bioavailable botanical extracts just as the CEO expects.
About Stock Market Media Group
SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. For more information and to read disclaimers and disclosures: www.stockmarketmediagroup.com.
Contact:

Stock Market Media Group
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Class Action Over Alleged Deception

Updated Category News Views 0

Unpacking the Innventure Debacle Innventure, Inc. (NASDAQ:INV) seems to have landed itself in hot water, and not the relaxing kind. The revelation that its grand AI data center project in Ontario might never have existed has stirred up quite a storm among shareholders. This isn't just some run-of-the-mill oversight. We're talking about allegations of concocted stories...

Continue Reading
Smart Buying in Hilton Head: Second-Home Key Insights

Updated Category News Views 1

Choosing Your Slice of Paradise in Hilton Head Picture this—not just a sandy paradise for vacationing, but a hotspot for second-home buyers weighing their options like they're sizing up their next big investment. Enter Hilton Head, S.C., a place where strategic move means scooping up properties that marry lifestyle with fiscal savvy. Sizing Up the Dream: More Than Just...

Continue Reading
UWM's $603M Hedge Loss Sparks Class Action Turmoil

Updated Category News Views 2

UWM's Roller Coaster: From Acquisition Ambitions to Legal Strife Oh, the sweet smell of ambition—only sometimes, it leads you to absolute chaos. Just ask UWM Holdings Corporation (NYSE: UWMC), the mortgage lender who’s found itself neck-deep in legal trouble after a hedging disaster unfolded. Here's the scoop. Back in December 2025, UWM decided they wanted to add a...

Continue Reading
Medtronic's $700M Move with Cornerstone Robotics

Updated Category News Views 4

Medtronic Dives Deeper into Robotic Surgery You've got to hand it to Medtronic. They know how to make a splash, this time by slinging $700 million to lock arms with Cornerstone Robotics. Now, why do you reckon a giant like Medtronic is shelling out that kind of cash? Simple—the robotic-assisted surgery sector is a goldmine waiting to be mined. So they’re strapping on...

Continue Reading
Senior Care's Future: AI and Expert Insights Collide

Updated Category News Views 1

The Inflection Point in Senior Care We’re standing at a crossroads, folks. The senior care industry is feeling the pressure from all sides: a growing aging population, relentless staffing shortages, and increasing demands for transparency. So, what do you do when you're trying to keep a sinking ship afloat? Well, Sensi.AI reckons it’s time to call in the big guns. A...

Continue Reading
Nutex Health Breach: Legal Scrutiny and Risks Rise

Updated Category News Views 2

Cyberattack Unravels at Nutex Health Not just another day in the office for Nutex Health. The Houston-based micro-hospital operator, envisioned as a go-to for healthcare with its 28 facilities across 12 states, now finds itself plunged into a data nightmare. On August 24, 2026, they blew the whistle on unauthorized network activity. By August 31, it wasn’t just a minor...

Continue Reading
Exploring Denture to Implant Solutions with Dr. Miller

Updated Category News Views 3

The Changing Face of Tooth Replacement Let's dive into teeth. We're talking dentures, implants, and the rest of the gang that live in the world of full mouth replacements. Dr. Christopher Glenn Miller’s insights shared with HelloNation zero in on the evolution of tooth replacement options. Gone are the days of clunky dentures being your only shot. From sucking gum to...

Continue Reading
Schlotzsky’s Deli Reinvents Philly Cheesesteak Classic

Updated Category News Views 5

Philly Cheesesteak Gets a Schlotzsky's Twist Well, folks, Schlotzsky's Deli has decided to mess with the legend itself—introducing their fresh take on the iconic Philly Cheesesteak. Now before you roll your eyes, give a listen. They're not just slapping steak and cheese onto a bun. They're throwing out a lineup that includes subs, calzones, and flatbreads. That's right,...

Continue Reading
ONTO Faces Fiduciary Duty Investigation Alert

Updated Category News Views 2

Possible Fiduciary Abuses at Onto Innovation Imagine you’re cruising down the investment highway when, bam, an alert like this pops up in your rearview mirror. It’s time to hit the brakes and figure out what Levi & Korsinsky is up to with this investigation into Onto Innovation Inc. (NYSE: ONTO). They're sniffing around possible breaches of fiduciary duties by some of...

Continue Reading
Tranter's New Press Boosts Vänersborg Operations

Updated Category News Views 1

Tranter's Bold Move in Manufacturing No smoke and mirrors about it—Tranter's pulling out the big guns in Vänersborg with a shiny new 5,000-metric-ton press. And why not? As heat exchangers become hotter commodities, you've got to gear up to meet the demand or watch customers drift. This isn't just a new toy; it's a weapon for dominating growing markets. Precision and...

Continue Reading

Top 5 Most Recently Viewed Articles

Adial Pharmaceuticals Advances AD04 Following FDA Meeting

Updated Category News Views 217

Positive Developments for Adial Pharmaceuticals and AD04 Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a biopharmaceutical company dedicated to addressing addiction and related disorders, recently received significant updates from its End of Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA). This meeting, which was held to discuss the development of...

Continue Reading
Tradr Unveils Innovative 2X Leveraged ETFs for Quantum Stocks

Updated Category News Views 153

Exciting New ETFs from Tradr ETFs Tradr ETFs has just launched innovative financial products that cater specifically to traders keen on quantum computing technology. Among the new offerings are the Tradr 2X Long QUBT Daily ETF and the Tradr 2X Long RGTI Daily ETF. These funds are designed to provide traders with 200% daily exposure to Quantum Computing Inc. (NASDAQ: QUBT)...

Continue Reading
36Kr Holdings Inc. Launches European Central Station Initiative

Updated Category News Views 185

36Kr Holdings Inc. (NASDAQ: KRKR) made waves back in 2024 by launching the 36Kr European Central Station, a bold move aimed at expanding its foothold in the global market. The chatter around this initiative was palpable as traders eyed how this could reshape connections between Chinese startups and international players. You had to wonder—would it just be another flash...

Continue Reading
Apple's Leadership Changes and Upcoming Innovations Unveiled

Updated Category News Views 228

Apple's Recent Executive Changes Impacting the Tech Giant This past week brought forth noteworthy changes and developments at Apple Inc. (NASDAQ: AAPL), illustrating the company’s adaptability in a fast-evolving technology landscape. From potential executive exits to a shift in operational strategies, Apple is poised for significant transformations that aim to...

Continue Reading
Experian Dividend Exchange Rate Announcement and Key Details

Updated Category News Views 157

Experian Announces Dividend Exchange Rate Experian (OTC: EXPGF), a prominent global information services provider, has recently announced the exchange rate for its forthcoming first interim dividend. This dividend payment, which is set at 19.25 US cents per share, presents an excellent opportunity for investors. It is crucial for shareholders to take note of the details...

Continue Reading